Chondroitin Sulfate Proteoglycan 4 and Its Potential As an Antibody Immunotherapy Target across Different Tumor Types

Overexpression of the chondroitin sulfate proteoglycan 4 (CSPG4) has been associated with the pathology of multiple types of such as melanoma, breast cancer, squamous cell carcinoma, mesothelioma, neuroblastoma, adult and pediatric sarcomas, and some hematological cancers. CSPG4 has been reported to...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kristina M. Ilieva, Anthony Cheung, Silvia Mele, Giulia Chiaruttini, Silvia Crescioli, Merope Griffin, Mano Nakamura, James F. Spicer, Sophia Tsoka, Katie E. Lacy, Andrew N. J. Tutt, Sophia N. Karagiannis
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2018-01-01
Serie:	Frontiers in Immunology
Soggetti:	CSPG4 MCSP HMW-MAA NG2 melanoma triple-negative breast cancer
Accesso online:	http://journal.frontiersin.org/article/10.3389/fimmu.2017.01911/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!